A Phase 4 interventional study of Ultrasound-guided combined perineural and intramuscular dextrose injection. in Bell Palsy, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-27.
Sponsored by Al-Azhar University · Phase 4, Interventional, and Treatment
Bell's palsy (BP) is characterized by idiopathic acute weakness of the facial muscles associated with compression of the facial nerve. The present prospective study sought to evaluate the clinical efficacy of ultrasound-guided combined perineural and intramuscular dextrose injection for management of refractory Bell's palsy. The study included 30 patients with Bell's palsy with House-Brackmann scale ≥ 3 who were refractory to standard medical treatment after 3 months of disease onset. They received ultrasound-guided combined perineural and intramuscular dextrose injection. Clinical outcome was assessed using the House-Brackmann scale.
120 studies on the registry are indexed under Bell Palsy; 38 are open to participants now.
This study's enrollment of 30 is below the median of 50 across 93 interventional studies indexed under Bell Palsy.
Browse Bell Palsy studies →Al-Azhar University is the lead sponsor of 505 studies on the registry; 167 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
- The study included 30 patients with Bell's palsy diagnosed according to the recommendations of American Academy of Otolaryngology-Head and Neck Surgery Foundation
Exclusion Criteria:
Ultrasound-guided combined perineural and intramuscular dextrose injection.
Procedure: Ultrasound-guided combined perineural and intramuscular dextrose injection.
Ultrasound-guided combined perineural and intramuscular dextrose injection.
House Brackmann scale
House Brackmann scale
Time frame: 3 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Al-Azhar University